{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:59:14Z","timestamp":1763564354257,"version":"3.37.3"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>There are currently different management guidelines for patients undergoing elective total hip arthroplasty (THA) or total knee arthroplasty (TKA) that are on long-term anticoagulation. The timing of discontinuation and restarting the anticoagulation is challenging during the postoperative care, which often involves general practitioners and physiotherapists.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The systematic review followed the PRISMA guidelines and included 3 databases: PubMed\/MEDLINE, EMBASE, and Web of Science Core Collection. It was registered in the International Prospective Register for Systematic Reviews and Meta-analysis (PROSPERO) under the registration number: CRD42023408906. The risk of bias assessment was performed using the Methodological index for non-randomized studies (MINORS) criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Six retrospective studies involving 727 patients with therapeutic anticoagulation (1,540 controls) for elective THA, TKA and revision arthroplasty have been included. The follow-up ranged from 30 days to 1 year postoperatively. All studies evaluated outcomes of warfarin therapeutic anticoagulation versus prophylactic dosages of one or more of the following: warfarin, aspirin, low-molecular-weight heparin (LMWH) and unfractionated low-dose heparin (UFH). One study did not discontinue therapeutic anticoagulation. Two studies reported no significant differences in complications between groups, whilst 3 studies had significantly higher rates of superficial wound infections, revision surgeries, postoperative haematomas, and prosthetic joint infections (PJI).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Different anticoagulation-related perioperative management strategies achieve different outcomes following elective arthroplasty in patients with therapeutic chronic anticoagulation. There is contradictory evidence regarding the need for the discontinuation of therapeutic warfarin. Retrospective data showed that individual risk stratification with multi-modal prophylaxis resulted in minimal complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Level of Evidence<\/jats:title>\n                  <jats:p>Systematic Review of Level III studies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/fampra\/cmae020","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T02:42:08Z","timestamp":1713580928000},"page":"629-637","source":"Crossref","is-referenced-by-count":3,"title":["Outcomes of different perioperative management strategies of patients on chronic anticoagulation in elective total hip and knee arthroplasty: a systematic review"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3709-4322","authenticated-orcid":false,"given":"Diana","family":"Andronic","sequence":"first","affiliation":[{"name":"School of Allied Health, Faculty of Health, Education, Medicine & Social Care ARU , Cambridge ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3743-7033","authenticated-orcid":false,"given":"Octavian","family":"Andronic","sequence":"additional","affiliation":[{"name":"Department of Trauma and Orthopaedics, Balgrist University Hospital , Z\u00fcrich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0860-2666","authenticated-orcid":false,"given":"Elias","family":"Ammann","sequence":"additional","affiliation":[{"name":"Department of Trauma and Orthopaedics, Perth Orthopaedics and Sports Medicine Centre , Perth ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2982-1232","authenticated-orcid":false,"given":"Edward","family":"Pravin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Curtin University , Perth ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3583-5342","authenticated-orcid":false,"given":"Rachael","family":"Cubberley","sequence":"additional","affiliation":[{"name":"School of Allied Health, Faculty of Health, Education, Medicine & Social Care ARU , Cambridge ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"issue":"9","key":"2024100903330857600_CIT0001","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/phar.2158","article-title":"Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010\u20132017","volume":"38","author":"Zhu","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"12","key":"2024100903330857600_CIT0002","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.amjmed.2015.05.044","article-title":"National trends in ambulatory oral anticoagulant use","volume":"128","author":"Barnes","year":"2015","journal-title":"Am J Med"},{"issue":"2","key":"2024100903330857600_CIT0003","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/medicina57020188","article-title":"Perioperative management of chronic antithrombotic agents in elective hip and knee arthroplasty","volume":"57","author":"Santana","year":"2021","journal-title":"Medicina (B Aires)"},{"issue":"7","key":"2024100903330857600_CIT0004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1302\/2058-5241.5.200010","article-title":"Kinematic alignment in total knee arthroplasty","volume":"5","author":"Nisar","year":"2020","journal-title":"EFORT Open Rev"},{"issue":"17","key":"2024100903330857600_CIT0005","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2106\/JBJS.17.01617","article-title":"Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030","volume":"100","author":"Sloan","year":"2018","journal-title":"JBJS"},{"issue":"3","key":"2024100903330857600_CIT0006","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/fampra\/cmh313","article-title":"How research-conscious GPs make decisions about anticoagulation in patients with atrial fibrillation: a qualitative study","volume":"21","author":"Lipman","year":"2004","journal-title":"Fam Pract"},{"issue":"4","key":"2024100903330857600_CIT0007","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.3390\/ijms24043169","article-title":"A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology","volume":"24","author":"Pastori","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2024100903330857600_CIT0008","first-page":"479","article-title":"HIV-positive patients are at increased risk of venous thromboembolism after total joint replacement","volume":"29","author":"Olson","year":"2021","journal-title":"JAAOS"},{"issue":"3","key":"2024100903330857600_CIT0009","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.arth.2017.09.067","article-title":"Postoperative complications of total joint arthroplasty in obese patients stratified by BMI","volume":"33","author":"Zusmanovich","year":"2018","journal-title":"J Arthroplasty"},{"issue":"9 Suppl","key":"2024100903330857600_CIT0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.arth.2016.02.077","article-title":"Individualized risk model for venous thromboembolism after total joint arthroplasty","volume":"31","author":"Parvizi","year":"2016","journal-title":"J Arthroplasty"},{"issue":"23","key":"2024100903330857600_CIT0011","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2106\/JBJS.N.00077","article-title":"Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates","volume":"96","author":"Hart","year":"2014","journal-title":"JBJS"},{"issue":"9","key":"2024100903330857600_CIT0012","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.arth.2017.04.048","article-title":"Incidence and risk factors for blood transfusion in total joint arthroplasty: analysis of a statewide database","volume":"32","author":"Slover","year":"2017","journal-title":"J Arthroplasty"},{"issue":"5","key":"2024100903330857600_CIT0013","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.rbo.2017.05.018","article-title":"Use of oral anticoagulants for the prevention of thromboembolic events in the post-operative period of hip arthroplasty: a systematic review","volume":"53","author":"Trevisol","year":"2018","journal-title":"Revista brasileira de ortopedia"},{"issue":"6","key":"2024100903330857600_CIT0014","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3928\/01477447-20190906-02","article-title":"Anticoagulation in revision total joint arthroplasty: a retrospective review of 1917 Cases","volume":"42","author":"Manista","year":"2019","journal-title":"Orthopedics"},{"key":"2024100903330857600_CIT0015","first-page":"S0883","article-title":"Chronic anticoagulation is associated with increased risk for postoperative complications following aseptic revision","author":"Heo","year":"2024","journal-title":"J Arthroplasty"},{"issue":"10294","key":"2024100903330857600_CIT0016","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"2","key":"2024100903330857600_CIT0017","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2522\/ptj.20150264","article-title":"Role of physical therapists in the management of individuals at risk for or diagnosed with venous thromboembolism: evidence-based clinical practice guideline","volume":"96","author":"Hillegass","year":"2016","journal-title":"Phys Ther"},{"issue":"1","key":"2024100903330857600_CIT0018","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/fampra\/cmh609","article-title":"Prospective study of elderly people comparing treatments following first primary care consultation for a symptomatic hip or knee","volume":"22","author":"Linsell","year":"2005","journal-title":"Fam Pract"},{"issue":"6","key":"2024100903330857600_CIT0019","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/fampra\/cmw071","article-title":"Pain distribution in primary care patients with hip osteoarthritis","volume":"33","author":"Poulsen","year":"2016","journal-title":"Fam Pract"},{"issue":"1","key":"2024100903330857600_CIT0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/fampra\/cmq066","article-title":"Referral recommendations for osteoarthritis of the knee incorporating patients\u2019 preferences","volume":"28","author":"Musila","year":"2011","journal-title":"Fam Pract"},{"key":"2024100903330857600_CIT0021","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"2024100903330857600_CIT0022","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.2106\/00004623-200512000-00006","article-title":"Level of evidence in orthopaedic journals","volume":"87","author":"Obremskey","year":"2005","journal-title":"J Bone Joint Surg Am"},{"issue":"12","key":"2024100903330857600_CIT0023","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.arthro.2018.10.002","article-title":"Research pearls: how do we establish the level of evidence","volume":"34","author":"Hohmann","year":"2018","journal-title":"Arthroscopy"},{"issue":"9","key":"2024100903330857600_CIT0024","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (Minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"issue":"12","key":"2024100903330857600_CIT0025","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1016\/j.arthro.2021.04.062","article-title":"Lack of conclusive evidence of the benefit of biologic augmentation in core decompression for nontraumatic osteonecrosis of the femoral head: a systematic review","volume":"37","author":"Andronic","year":"2021","journal-title":"Arthroscopy"},{"issue":"17","key":"2024100903330857600_CIT0026","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.2106\/JBJS.L.00882","article-title":"Patients with atrial fibrillation undergoing total joint arthroplasty increase hospital burden","volume":"95","author":"Aggarwal","year":"2013","journal-title":"JBJS"},{"issue":"7_Supple_B","key":"2024100903330857600_CIT0027","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1302\/0301-620X.102B7.BJJ-2019-1559.R1","article-title":"Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty","volume":"102-B","author":"Gonzalez Della Valle","year":"2020","journal-title":"Bone Joint J"},{"issue":"1","key":"2024100903330857600_CIT0028","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.arth.2012.06.001","article-title":"Complications related to therapeutic anticoagulation in total hip arthroplasty","volume":"28","author":"McDougall","year":"2013","journal-title":"J Arthroplasty"},{"issue":"1","key":"2024100903330857600_CIT0029","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11999-009-1128-8","article-title":"Discontinuation of warfarin is unnecessary in total knee arthroplasty","volume":"468","author":"Rhodes","year":"2010","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"2024100903330857600_CIT0030","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.arth.2012.11.003","article-title":"Complications of perioperative warfarin therapy in total knee arthroplasty","volume":"29","author":"Simpson","year":"2014","journal-title":"J Arthroplasty"},{"issue":"2","key":"2024100903330857600_CIT0031","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.knee.2004.06.004","article-title":"Arthrofibrosis following total knee replacement; does therapeutic warfarin make a difference","volume":"12","author":"Walton","year":"2005","journal-title":"Knee"},{"issue":"12","key":"2024100903330857600_CIT0032","doi-asserted-by":"crossref","first-page":"768","DOI":"10.5435\/00124635-201112000-00007","article-title":"Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty","volume":"19","author":"Mont","year":"2011","journal-title":"JAAOS"},{"issue":"12","key":"2024100903330857600_CIT0033","doi-asserted-by":"crossref","first-page":"729","DOI":"10.5435\/00124635-201012000-00003","article-title":"Perioperative management of chronic anticoagulation in orthopaedic surgery","volume":"18","author":"Thakur","year":"2010","journal-title":"JAAOS"},{"issue":"7","key":"2024100903330857600_CIT0034","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the american college of cardiology clinical expert consensus document task force","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"2024100903330857600_CIT0035","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"issue":"5","key":"2024100903330857600_CIT0036","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jamcollsurg.2018.08.183","article-title":"American college of surgeons\u2019 guidelines for the perioperative management of antithrombotic medication","volume":"227","author":"Hornor","year":"2018","journal-title":"J Am Coll Surg"},{"issue":"4","key":"2024100903330857600_CIT0037","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/bjh.14344","article-title":"Haematology the BC of S for. Peri-operative management of anticoagulation and antiplatelet therapy","volume":"175","author":"Keeling","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"2024100903330857600_CIT0038","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.accpm.2018.10.004","article-title":"Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR)","volume":"38","author":"Godier","year":"2019","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"5","key":"2024100903330857600_CIT0039","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"2","key":"2024100903330857600_CIT0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","article-title":"Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The HAS-BLED (Hypertension, Abnormal Renal\/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs\/Alcohol Concomitantly) Score","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2024100903330857600_CIT0041","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1538-7836.2011.04378.x","article-title":"Bleeding risk in \u201creal world\u201d patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort","volume":"9","author":"Olesen","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2024100903330857600_CIT0042","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3390\/jcm11071754","article-title":"The risk of bleeding and adverse events with clopidogrel in elective hip and knee arthroplasty patients","volume":"11","author":"Wu","year":"2022","journal-title":"J Clin Med"},{"key":"2024100903330857600_CIT0043","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/BLO.0b013e31805b7681","article-title":"2007 ABJS Nicolas Andry Award: three decades of clinical, basic, and applied research on thromboembolic disease after THA: rationale and clinical results of a multimodal prophylaxis protocol","volume":"459","author":"Salvati","year":"2007","journal-title":"Clin Orthop Relat Res"},{"issue":"1 Suppl A","key":"2024100903330857600_CIT0044","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1302\/0301-620X.98B1.36409","article-title":"The modern, hybrid total hip arthroplasty for primary osteoarthritis at the Hospital for Special Surgery","volume":"98-B","author":"Gonz\u00e1lez Della Valle","year":"2016","journal-title":"Bone Joint J"},{"key":"2024100903330857600_CIT0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jor.2019.06.024","article-title":"Interruption of long-term warfarin is not necessary in patients undergoing total hip arthroplasty","volume":"17","author":"Mussa","year":"2020","journal-title":"J Orthop"},{"issue":"16","key":"2024100903330857600_CIT0046","article-title":"Warfarin cessation is non-essential in patients undergoing total knee arthroplasty\u2014a case-control study","volume":"10","author":"Phillips","year":"2015","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"2024100903330857600_CIT0047","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12874-018-0576-9","article-title":"A systematic survey shows that reporting and handling of missing outcome data in networks of interventions is poor","volume":"18","author":"Spineli","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"2024100903330857600_CIT0048","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/ATVBAHA.114.303400","article-title":"Clinical experience with novel oral anticoagulants for thromboprophylaxis after elective hip and knee arthroplasty","volume":"35","author":"Messerschmidt","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2024100903330857600_CIT0049","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1160\/TH10-09-0601","article-title":"Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty","volume":"105","author":"Turpie","year":"2011","journal-title":"Thromb Haemost"},{"issue":"1","key":"2024100903330857600_CIT0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1160\/TH13-08-0666","article-title":"A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment","volume":"111","author":"Turpie","year":"2014","journal-title":"Thromb Haemost"},{"issue":"3","key":"2024100903330857600_CIT0051","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.thromres.2010.03.021","article-title":"Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: A pooled analysis of three trials","volume":"126","author":"Friedman","year":"2010","journal-title":"Thromb Res"},{"issue":"4","key":"2024100903330857600_CIT0052","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11239-009-0309-3","article-title":"Incidence and cost burden of post-thrombotic syndrome","volume":"28","author":"Ashrani","year":"2009","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"2024100903330857600_CIT0053","first-page":"861","article-title":"New oral anticoagulants and perioperative management of anticoagulant_antiplatelet agents","volume":"43","author":"Jilani","year":"2014","journal-title":"Australian Family Physician (AFP)"},{"issue":"7381","key":"2024100903330857600_CIT0054","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmj.326.7381.153","article-title":"Anticoagulation in hospitals and general practice","volume":"326","author":"Blann","year":"2003","journal-title":"BMJ"},{"issue":"10","key":"2024100903330857600_CIT0055","doi-asserted-by":"crossref","first-page":"e14552","DOI":"10.1111\/ijcp.14552","article-title":"Effectiveness of apixaban versus enoxaparin in preventing wound complications and deep venous thrombosis following total knee replacement surgery: A retrospective study","volume":"75","author":"Ali Hasan","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"2","key":"2024100903330857600_CIT0056","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/CM9.0000000000001305","article-title":"Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trial","volume":"134","author":"Ren","year":"2021","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"2024100903330857600_CIT0057","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12185-013-1445-2","article-title":"Evaluating the efficacy and safety of apixaban, a new oral anticoagulant, using Bayesian meta-analysis","volume":"98","author":"Villa","year":"2013","journal-title":"Int J Hematol"}],"container-title":["Family Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/fampra\/article-pdf\/41\/5\/629\/59644704\/cmae020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/fampra\/article-pdf\/41\/5\/629\/59644704\/cmae020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T03:33:25Z","timestamp":1728444805000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/fampra\/article\/41\/5\/629\/7654056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,19]]},"published-print":{"date-parts":[[2024,10,8]]}},"URL":"https:\/\/doi.org\/10.1093\/fampra\/cmae020","relation":{},"ISSN":["1460-2229"],"issn-type":[{"type":"electronic","value":"1460-2229"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,4,19]]}}}